CURE Pharmaceutical Announces Positive Findings from Study at Cincinnati Children’s Hospital Medical Center (CCHMC) Using CURE’s Proprietary, Oral Thin Film (OTF) High, Single Dose Vitamin D in Pediatric Patients Pre- and Post-Hematopoietic Stem Cell Transplantation (HSCT)

by IR Team | May 12, 2022 | Press Releases

CURE’s Patented and Proprietary OTF Vitamin D Found to be More Effective than Standard Supplementation in Achieving pre- and post-Surgery Vitamin D Sufficiency Necessary to Reduce Immune-Mediated Damage such as Graft Versus Host Disease (GVHD)CCHMC to Seek...

Sera Labs Inc. Products Now Available at Walmart, Bed Bath & Beyond, CVS and Target.com

by IR Team | Apr 14, 2022 | Press Releases

LOS ANGELES, April 14, 2022 — Sera Labs, a wholly subsidiary of CURE Pharmaceutical Holding Corp. (OTC: CURR), today announced its Seratopical Revolution skincare line will be sold at select Walmart Stores, as well as CVS, and Bed Bath & Beyond stores. Sera...

CURE Pharmaceutical and Milagro Pharmaceuticals Collaborate for Registration and Approval to Sell Sildenafil Oral Thin Film in Mexico

by IR Team | Mar 3, 2022 | Press Releases

COFEPRIS (Mexico’s equivalent of the US FDA) grants authorization for the manufacture, distribution and sale in Mexico of CURE’s Sildenafil, Vitamin D3, Electrolyte, Energy, and Sleep products in CURE’s patented Oral Thin Film (OTF) dose form...

Sera Labs, a Subsidiary of CURE Pharmaceutical, Consummates Exclusive International Distribution Agreement With Leading Canadian Distributor

by IR Team | Dec 9, 2021 | Press Releases

Northern Response International To Distribute Seratopical Revolution® Masstige LineLOS ANGELES and TORONTO, Dec. 09, 2021 — The Sera Labs, a wholly owned subsidiary of CURE Pharmaceutical Holdings (OTCQB: CURR) today announced its global expansion into...

CURE Pharmaceutical Receives Patent Approval for Its CUREfilm Blue™ Technology

by IR Team | Nov 16, 2021 | Press Releases

OXNARD, Calif. – CURE Pharmaceutical Holding Corp. (OTC: CURR), a technology focused, vertically integrated drug delivery and product development company focused on pharmaceutical and health & wellness products, announced today that it received an issue...